This year’s ID Week will take place October 19-22, 2025, in Atlanta, GA. ID Week is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Following is a list of ID faculty and ID Fellows, and their activities for the week.
ID Faculty
Presentations
Monday, October 20
10:30am – 10:42am, Location: B207-B208
Tessa Andermann – 74 – Clinical and Microbiology Outcomes of Bloodstream Infections (BS) in Adults Undergoing Allogeneic Hematopoietic Stem Cell
10:30 am – 10:55 am, Location: Thomas B. Murphy Ballroom 4
Melissa Miller – 71 – Clinical Application and Appraisal of Culture-Independent Metagenomics-Based Diagnostics
11:20am – 11:45am, Location: Thomas B Murphy Ballroom 4
Jonathan Parr – 73 – Sequencing-Informed Development of a Globally Effective Syphilis Vaccine
Tuesday, October 21
4:45 pm – 6:00pm, Location: B405-B407
David Weber – 183 – SHEA Lectureship: Emerging and Relevant Issues Impacting Our Community
Wednesday, October 22
8:00am – 9:00am, Location B308-B309
Luther Bartelt – One Size Fits One: Toward Individualized Management of Infectious Diseases
8:20am – 8:40am, Location B308-B309
Anne Friedland, Laboratory-Guided Isolate-Specific Treatment Modifications: Mycobacterium abscesses (Clinical)
10:45am – 11:00am, Location: B213-B214
Natalie Mackow – 556 – Using a novel Anaerobic Activity Index to assess risk for poor outcomes in burn patients in a burn intensive care unit
12:00 pm – 12:25 pm, Location: BugHub World Stage
Asher Schranz – Billing Code G2211
Posters
Monday, October 20
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Heather Henderson (presenting), Lindsay Brown, Alex Commanday, Claire Farel, Joseph Eron, Sonia Napravnik, Amanda Moy (P-270) Comparing Regression and Machine Learning Methods for Predicting Readmission Risk among People with HIV
Tuesday, October 21
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Anne Lachiewicz – (P-1353) Earlier Cefiderocol Use was Associated with Better Outcomes for Challenging Gram-Negative Bacterial Infections: US Results From the Global Observational PROVE Study
12:15pm – 1:30pm, Location: Poster Hall B4-B5
David Weber – (P-905) Applying Encounter-level Risk-Adjustment for Standardized Antimicrobial Administration Ratios (SAAR): Is it meaningful?
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Nikolaos Mavrogiorgos – (P-804) Dulling Reflexes: Refining Criteria for Reflex Urine Cultures in Outpatient Areas and Emergency Departments to Decrease Inappropriate Antimicrobial Use
Wednesday, October 22
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Luther Bartelt, Anne Friedland, Asher Schranz, David van Duin – (P-1856) Desirability of Outcome Ranking Analysis Framework for Patients on Outpatient Parenteral Antimicrobial Therapy: A Proof-of-Concept Study in Immunocompromised Patients Receiving Daptomycin or Vancomycin
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Claire Farel, Mary Catherine Bowman, Asher Schranz – (P-1862) Telehealth in Outpatient Parenteral Antimicrobial Therapy (OPAT): Utilization Patterns and Patient Outcomes
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Heather Henderson (presenting), David van Duin – (P-2068) Area Deprivation Is Linked to Prevalence of Multidrug Resistance in Enterobacterales Clinical Isolates
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Thomas Holowka (presenting), Nikolaos Mavrogiorgos, Elizabeth Arant, Michael Herce, Claire Farel, Luther Bartelt – (P-2050) Enhancing Patient Outcomes and System Efficiency Through Active Screening for Recurrent Clostridioides difficile and Specialty Treatment at an Infectious Diseases Clinic
12:15pm – 1:30pm, Location: Poster Hall B4-B5
Ning Zhang, MS, and Katie Mollan, MS, (Epidemiology Students) – P-1646 – Return to Work or School Among Adults After Symptomatic SARS-CoV-2 Infection.
Award Recognition
Wednesday, October 22
9:15 am – 10:00 am, Location: Ballroom (Hall B1)
Becky White will receive the HIVMA Adaora Adimora Citation Award during the Joseph E. Smadel Lecture.
Moderating
Wednesday, October 22
8:00am – 9:00am, Location: B203
Asher Schranz -187 – Getting Paid for What You Already Do: Update on Coding for the ID Provider
ID Fellows
Monday, October 20
12:15 – 1:30 pm (P-96) Location: Poster Hall B4-B5
Co-Author: Siddartha Guru: Comparative Outcomes of Dalbavancin vs. Standard Intravenous Antibiotics in Staphylococcus aureus Osteomyelitis: A Retrospective, Propensity-Matched Cohort Study Using Real-World Data
12:15 – 1:30 pm Poster Hall B4-B5
Presenting Author: Siddartha Guru, MD: (P-140) Incidence of Heart Failure and Valvular Diseases After Infective Endocarditis: A Propensity-Matched Cohort Study
12:15 – 1:30 pmLocation: Poster Hall B4-B5
Presenting Author: Stephanie Sweitzer, MD, MSPH
Co-Author(s): Erika Samoff, PhD, MPH, Victoria Mobley, MD, MPH, Arlene Sena, MD, MPH(P-740) Engagement in the Syphilis Screening Cascade among Pregnant Women in North Carolina
12:15 – 1:30 pm, Presenting Author: Siddartha Guru, MD
(P-759) Comparative Effectiveness of Linezolid and Clindamycin for Necrotizing Fasciitis: Mortality and Microbiologic Outcomes in a Real-World Cohort
Location: Poster Hall B4-B5
Tuesday, October 21
12:15 – 1:30 pm (P-1346) Location: Poster Hall B4-B5
Co-Author: Siddartha Guru, MD, Comparative Effectiveness of Parenteral Daptomycin Versus Vancomycin Among Patients with Methicillin-resistant Staphylococcus aureus (MRSA) Endogenous endophthalmitis: A Retrospective Analysis
Wednesday, October 22
12:15 – 1:30 pm (P-2162) Location: Poster Hall B4-B5
Presenting Author: Swarn Arya, DO, Is complete avoidance to anti-anerobic therapy possible for empiric fever and neutropenia therapy?
12:15 – 1:30 pm, (P-1754) Location: Poster Hall B4-B5
Co-Author: Siddartha Guru, MD, Reduced Risk of Acute Kidney Injury with Montelukast in Vancomycin-Treated Patients: A Propensity-Matched Cohort Study